Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension
Author:
Affiliation:
1. Department of Biomedicine, Pharmacology; Aarhus University; Aarhus C Denmark
2. Clinic for Plastic, Aesthetic and Hand Surgery; Otto-von-Guericke-University Magdeburg; Magdeburg Germany
Publisher
Wiley
Subject
Pharmacology,Toxicology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12800/fullpdf
Reference56 articles.
1. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension;Whitworth;J Hypertens,2003
2. Worldwide prevalence of hypertension: a systematic review;Kearney;J Hypertens,2004
3. Awareness, treatment and control of hypertension in Denmark. The Inter99 study;Sehestedt;Blood Press,2007
4. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials;Turnbull;Lancet,2003
5. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure;Chobanian;Hypertension,2003
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-07-04
2. Development and Validation of Stability-indicating HPLC Method for Estimation of Azilsartan in Pharmaceutical and Solid Lipid Nanoparticles;Indian Journal of Pharmaceutical Education and Research;2024-03-06
3. Association between Mycoplasma pneumoniae infection, high‑density lipoprotein metabolism and cardiovascular health (Review);Biomedical Reports;2024-01-18
4. Empirical scaling factor for predicting human pharmacokinetic profiles of disproportionate metabolites using the Css–MRTpo method and chimeric mice with humanised livers;Xenobiotica;2023-09-02
5. Azilsartan Ameliorates Skeletal Muscle Wasting in High Fat Diet (HFD)-induced Sarcopenic Obesity in Rats via Activating Akt Signalling Pathway;Archives of Gerontology and Geriatrics;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3